Worldwide Trends in TAVR

By Ted E. Feldman, MD, MSCAI, FACC, FESC, and Bernard Prendergast, BMedSci, BM BS, MRCP, DM, FRCP, FESC

Risk Assessment for Transcatheter Aortic Valve Replacement

Understanding STS score, EuroSCORE, and frailty indices.

By Troels Højsgaard Jørgensen, MD, and Lars Søndergaard, MD, DMSc

Current Status and Expectations for Low-Risk TAVI Trials

An expert opinion on how current clinical trials will impact the future of TAVI procedures in low-risk patients.

With Marc Dweck, MD, PhD

Trends in United States TAVR Practice

An update on where TAVR is going as the technology matures in the United States.

By John C. Messenger, MD

Trends in European TAVI Practice

Current application of TAVI in Europe.

By Giuliano Costa, MD; Marco Barbanti, MD; and Corrado Tamburino, MD, PhD

East Meets West: Emerging Transcatheter Aortic Valve Technologies

Emerging valve systems and iterative technologies from around the world and how they could shape global practice going forward.

By Federico Mercanti, MD; Zhen-Gang Zhao, MD; Antoinette Neylon, MD, BCh; Mao Chen, MD, PhD; and Darren Mylotte, MD, BCh

TAVR Clinical Trials

A collection of ongoing and completed trials investigating TAVR procedures and devices. Our trial charts allow for comparison of multiple trials across many categories and are updated throughout the year as industry provides data.

Acute Right Ventricular Failure

A review of diagnosis and principles of percutaneous mechanical circulatory support to optimize RV preload, afterload, and contractility after acute RV failure.

By Ivan D. Hanson, MD, and James A. Goldstein, MD

The Evolving Story of Fractional Flow Reserve CT

An important and effective noninvasive test for evaluating ischemia without the need for additional testing or radiation exposure.

By Jonathon Leipsic, MD, FRCPC; Stephanie Sellers, PhD; and Frederick St. Goar, MD

SAVR Versus TAVR: Treating Intermediate-Risk Patients

A patient-centered debate on the safety, efficacy, and durability of transcatheter aortic valve replacement versus surgical aortic valve replacement for intermediate-risk patients.

With Bruce Rutkin, MD; S. Jacob Scheinerman, MD, FACS; and Issam D. Moussa, MD, MBA

The High-Performing Cardiovascular Service Line: Evolving Leadership and Governance in the Value Economy

How to create an intentional, carefully designed clinical strategy that establishes expected outcomes for care and creates standards for care delivery.

By Ginger Biesbrock, PA-C, MPH, MPAS, AACC, and Joel Sauer, MBA

Innovations (US)

Innovations (Europe)

An Interview With Alec Vahanian, MD

Dr. Vahanian shares his thoughts on the updated ESC/EACTS guidelines and the ongoing evolution of valvular intervention.